Literature DB >> 15812632

Ehlers-Danlos syndrome type IV and recurrent carotid-cavernous fistula: review of the literature, endovascular approach, technique and difficulties.

H A Desal1, F Toulgoat, S Raoul, B Guillon, S Bommard, E Naudou-Giron, E Auffray-Calvier, A de Kersaint-Gilly.   

Abstract

We report the follow-up of a previously published case (Forlodou et al. Neuroradiology 38:595-597, 1996) of carotido-cavernous fistulas (CCFs) in a patient presenting with type IV Ehlers-Danlos syndrome (EDS 4) that were successfully treated twice by an endovascular approach. Initial treatment with a detachable balloon was in 1994 for a right CCF, and, 8 years later, a left CCF was treated by selective transarterial occlusion of the cavernous sinus with coils. Unfortunately, the patient suffered from a spontaneous post-operative intracranial haemorrhage in the left hemisphere and died. Review of the literature, technical considerations for bilateral CCF and complication are discussed.

Entities:  

Mesh:

Year:  2005        PMID: 15812632     DOI: 10.1007/s00234-005-1378-4

Source DB:  PubMed          Journal:  Neuroradiology        ISSN: 0028-3940            Impact factor:   2.804


  9 in total

1.  [Direct carotid-cavernous fistula. Clinical, radiologic and therapeutic studies. Apropos of 49 cases].

Authors:  H Desal; F Leaute; E Auffray-Calvier; S Martin; B Guillon; R Robert; A De Kersaint-Gilly
Journal:  J Neuroradiol       Date:  1997-08       Impact factor: 3.447

2.  Clinical and genetic features of Ehlers-Danlos syndrome type IV, the vascular type.

Authors:  M Pepin; U Schwarze; A Superti-Furga; P H Byers
Journal:  N Engl J Med       Date:  2000-03-09       Impact factor: 91.245

Review 3.  Ehlers-Danlos syndrome with a spontaneous caroticocavernous fistula occluded by detachable balloon: case report and review of literature.

Authors:  P Forlodou; A de Kersaint-Gilly; J Pizzanelli; M P Viarouge; E Auffray-Calvier
Journal:  Neuroradiology       Date:  1996-08       Impact factor: 2.804

4.  Heterogeneity of the Ehlers-Danlos syndrome: description of three clinical types and a hypothesis to explain the basic defect(s).

Authors:  A P Barabas
Journal:  Br Med J       Date:  1967-06-03

5.  Three cases of spontaneous direct carotid cavernous fistulas associated with Ehlers-Danlos syndrome type IV.

Authors:  G M Debrun; V A Aletich; N R Miller; R J DeKeiser
Journal:  Surg Neurol       Date:  1996-09

Review 6.  Treatment of spontaneous carotid-cavernous fistula in Ehlers-Danlos syndrome by transvenous occlusion with Guglielmi detachable coils. Case report and review of the literature.

Authors:  A A Kanner; S Maimon; Z H Rappaport
Journal:  J Neurosurg       Date:  2000-10       Impact factor: 5.115

7.  Treatment of carotid-cavernous fistulas associated with Ehlers-Danlos syndrome.

Authors:  V V Halbach; R T Higashida; C F Dowd; S L Barnwell; G B Hieshima
Journal:  Neurosurgery       Date:  1990-06       Impact factor: 4.654

Review 8.  Spontaneous direct carotid-cavernous fistula in Ehlers-Danlos syndrome type IV: two case reports and a review of the literature.

Authors:  Hideki Chuman; Jonathan D Trobe; Elizabeth M Petty; Ulrike Schwarze; Melanie Pepin; Peter H Byers; John P Deveikis
Journal:  J Neuroophthalmol       Date:  2002-06       Impact factor: 3.042

9.  Remote vascular catastrophes after neurovascular interventional therapy for type 4 Ehlers-Danlos Syndrome.

Authors:  M B Horowitz; P D Purdy; R J Valentine; K Morrill
Journal:  AJNR Am J Neuroradiol       Date:  2000-05       Impact factor: 4.966

  9 in total
  13 in total

1.  Management of pseudoaneurysms in the intracranial segment of the internal carotid artery with covered stents specially designed for use in the intracranial vasculature: technical notes.

Authors:  Ming-Hua Li; Bu-Lang Gao; Yong-Li Wang; Chun Fang; Yong-Dong Li
Journal:  Neuroradiology       Date:  2006-08-31       Impact factor: 2.804

2.  A novel approach to the treatment of a direct carotid-cavernous fistula in a patient with Ehlers-Danlos syndrome type IV.

Authors:  Ichiro Nakagawa; Hun Soo Park; Takeshi Wada; Katsutoshi Takayama; Hiroyuki Nakagawa; Kimihiko Kichikawa; Hiroyuki Nakase
Journal:  BMJ Case Rep       Date:  2014-11-24

3.  Endovascular treatment in an unusual case of direct carotid cavernous fistula.

Authors:  Rajendra Gajanan Chavan; Ravindra Bhimrao Kamble; Vivek Bonde
Journal:  Neuroradiol J       Date:  2014-04-18

4.  Carotid-cavernous fistula in ehlers-danlos syndrome by pure transvenous approach.

Authors:  O Van Overmeire; K De Keukeleire; P Van Langenhove; L Defreyne
Journal:  Interv Neuroradiol       Date:  2006-06-15       Impact factor: 1.610

Review 5.  Ehlers-Danlos syndrome and neurological features: a review.

Authors:  Salvatore Savasta; Pietro Merli; Martino Ruggieri; Lucia Bianchi; Maria Valentina Spartà
Journal:  Childs Nerv Syst       Date:  2010-08-10       Impact factor: 1.475

6.  Spontaneous rupture of the spleen in type IV Ehlers-Danlos syndrome: report of a case.

Authors:  Antonio Privitera; Chaz Milkhu; Vivek Datta; Mazim Sayegh; Richard Cohen; Alastair Windsor
Journal:  Surg Today       Date:  2009-01-08       Impact factor: 2.549

Review 7.  Neurovascular manifestations of connective-tissue diseases: A review.

Authors:  Sarasa T Kim; Waleed Brinjikji; Giuseppe Lanzino; David F Kallmes
Journal:  Interv Neuroradiol       Date:  2016-08-10       Impact factor: 1.610

8.  Hereditary connective tissue diseases in young adult stroke: a comprehensive synthesis.

Authors:  Olivier M Vanakker; Dimitri Hemelsoet; Anne De Paepe
Journal:  Stroke Res Treat       Date:  2011-01-20

9.  Intracranial and extracranial multiple arterial dissecting aneurysms in rheumatoid arthritis: A case report.

Authors:  Ken Uekawa; Yasuyuki Kaku; Toshihiro Amadatsu; Hiroaki Matsuzaki; Yuki Ohmori; Takayuki Kawano; Shinya Hirata; Tomomi Yamaguchi; Tomoki Kosho; Akitake Mukasa
Journal:  Interv Neuroradiol       Date:  2020-10-20       Impact factor: 1.610

Review 10.  Ehlers-Danlos syndrome type IV.

Authors:  Dominique P Germain
Journal:  Orphanet J Rare Dis       Date:  2007-07-19       Impact factor: 4.123

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.